Diabetic Nephropathy
Osteoprotegerin levels increased in diabetic hemodialysis patients
Published in Obesity and Diabetes Week, November 1st, 2004
"Osteoprotegerin is a circulating osteoclastogenesis inhibitory factor and serum osteoprotegerin levels are elevated in hemodialysis patients. This study investigated whether osteoprotegerin levels correlated with various clinical parameters in hemodialysis patients. The subjects were 45 men and 37 women aged from 27 to 94 years (mean=60.4±13.9 years), and the duration of dialysis was 9-277 months (mean=89.5±64.7 months)," scientists writing in the journal Therapeutic Apheresis and Dialysis report.
"Serum osteoprotegerin levels were measured...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
More Articles from Obesity and Diabetes Week
- Childhood Obesity
Zinc nutritional status linked to hyperinsulinemia in obese children - Diabetes Pathogenesis
Insulin signaling impaired in people with family history of diabetes - Insulin Resistance
Growth hormone receptor gene disruption increases insulin sensitivity - Insulin Resistance
Insulin resistance reduces carbohydrate utilization during exercise - Leptin Studies
Leptin increases adiponectin but barely decreases resistin - Adipogenesis
Growth hormone treatment stimulates adiponectin gene expression in adipocytes - More from this issue of Obesity and Diabetes Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
